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Background
Allergic rhinitis (AR) is recognized as a major health pro-
blem worldwide. Allergen-specific immunotherapy (SIT) is
the only available treatment that can alter the natural
course of allergic disease. Recent findings in experimental
models of allergic rhinitis suggest that complement 3a and
5a regulate the development of maladaptive Th2 and
Th17 immunity. We investigated the changes of C3a, C5a,
IL-17a in the serum of patients treated by Sublingual
immune therapy (SLIT).
Methods
Symptoms were recorded in the allergy diary. The total
symptom medication scores were calculated based on
each symptoms and medication. We measured the C3a,
C5a, IL-17a levels in serum of the 20 identical subjects
by ELISA during 5 years.
Results
C3a and IL-17a showed significant decrease year by year
during 5 years (p < 0.01).
Conclusions
C3a and IL-17a can be objective biomarker for following
up the patients of SLIT.
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